Cutaneous melanoma: digital dermoscopy -essential tool for positive diagnosis

Por Simionescu, Olga, Costache, Mariana, Testori, Alessandro
Publicado em 2006

Interplay of microRNA and epigenetic regulation in the human regulatory network

Por Osella, Matteo, Riba, Andrea, Testori, Alessandro, Corà, Davide, Caselle, Michele
Publicado em 2014

Report from the second MIB (Melanoma Independent Board) Conference, 27–28 October 2014

Por Testori, Alessandro, Rossi, Carlo Riccardo, Ascierto, Paolo, de Lorenzo, Francesco, Mozzillo, Nicola
Publicado no Ecancermedicalscience (2015)

The role of Transposable Elements in shaping the combinatorial interaction of Transcription Factors

Por Testori, Alessandro, Caizzi, Livia, Cutrupi, Santina, Friard, Olivier, De Bortoli, Michele, Cora', Davide, Caselle, Michele
Publicado em 2012

Mitf regulation of Dia1 controls melanoma proliferation and invasiveness

Por Carreira, Suzanne, Goodall, Jane, Denat, Laurence, Rodriguez, Mercedes, Nuciforo, Paolo, Hoek, Keith S., Testori, Alessandro, Larue, Lionel, Goding, Colin R.
Publicado em 2006

UV exposure and melanoma prognostic factors : results from Clinical National Melanoma Registry (CNMR)

Por Montella, Maurizio, Gandini, Sara, Rossi, Carlo Riccardo, Testori, Alessandro, Mastrangelo, Giuseppe, Serraino, Diego, Budroni, Mario, Crispo, Anna, Grimaldi, Antonio Maria, Ascierto, Paolo Antonio
Publicado em 2014

Novel mutations in LMNA A/C gene and associated phenotypes

Por Petillo, Roberta, D'Ambrosio, Paola, Torella, Annalaura, Taglia, Antonella, Picillo, Esther, Testori, Alessandro, Ergoli, Manuela, Nigro, Gerardo, Piluso, Giulio, Nigro, Vincenzo, Politano, Luisa
Publicado no Acta Myol (2015)

The role of BRAF V600 mutation in melanoma

Por Ascierto, Paolo A, Kirkwood, John M, Grob, Jean-Jacques, Simeone, Ester, Grimaldi, Antonio M, Maio, Michele, Palmieri, Giuseppe, Testori, Alessandro, Marincola, Francesco M, Mozzillo, Nicola
Publicado em 2012

Recurrence and prognostic factors in patients with aggressive fibromatosis. The role of radical surgery and its limitations

Por Bertani, Emilio, Testori, Alessandro, Chiappa, Antonio, Misitano, Pasquale, Biffi, Roberto, Viale, Giuseppe, Mazzarol, Giovanni, De Pas, Tommaso, Botteri, Edoardo, Contino, Gianmarco, Verrecchia, Francesco, Bazolli, Barbara, Andreoni, Bruno
Publicado em 2012

Genome-wide activity of unliganded estrogen receptor-α in breast cancer cells

Por Caizzi, Livia, Ferrero, Giulio, Cutrupi, Santina, Cordero, Francesca, Ballaré, Cecilia, Miano, Valentina, Reineri, Stefania, Ricci, Laura, Friard, Olivier, Testori, Alessandro, Corà, Davide, Caselle, Michele, Di Croce, Luciano, De Bortoli, Michele
Publicado em 2014

The cost of unresectable stage III or stage IV melanoma in Italy

Por Maio Michele, Ascierto Paolo, Testori Alessandro, Ridolfi Ruggero, Bajetta Emilio, Queirolo Paola, Guida Michele, Romanini Antonella, Chiarion-Sileni Vanna, Pigozzo Jacopo, Di Giacomo Anna Maria, Calandriello Mario, Didoni Guido, van Baardewijk Marck, Konto Cyril, Lucioni Carlo
Publicado em 2012-11-01

The cost of unresectable stage III or stage IV melanoma in Italy

Por Maio, Michele, Ascierto, Paolo, Testori, Alessandro, Ridolfi, Ruggero, Bajetta, Emilio, Queirolo, Paola, Guida, Michele, Romanini, Antonella, Chiarion-Sileni, Vanna, Pigozzo, Jacopo, Di Giacomo, Anna Maria, Calandriello, Mario, Didoni, Guido, van Baardewijk, Marck, Konto, Cyril, Lucioni, Carlo
Publicado em 2012

Sunny Holidays before and after Melanoma Diagnosis Are Respectively Associated with Lower Breslow Thickness and Lower Relapse Rates in Italy

Por Gandini, Sara, De Vries, Esther, Tosti, Giulio, Botteri, Edoardo, Spadola, Giuseppe, Maisonneuve, Patrick, Martinoli, Chiara, Joosse, Arjen, Ferrucci, Pier Francesco, Baldini, Federica, Cocorocchio, Emilia, Pennacchioli, Elisabetta, Cataldo, Francesco, Bazolli, Barbara, Clerici, Alessandra, Barberis, Massimo, Bataille, Veronique, Testori, Alessandro
Publicado em 2013

Clinical experience with ipilimumab 10 mg/kg in patients with melanoma treated at Italian centres as part of a European expanded access programme

Por Altomonte, Maresa, Di Giacomo, Anna Maria, Queirolo, Paola, Ascierto, Paolo Antonio, Spagnolo, Francesco, Bajetta, Emilio, Calabrò, Luana, Danielli, Riccardo, de Rosa, Francesco, Maur, Michela, Chiarion-Sileni, Vanna, Ferrucci, Pier Francesco, Giannarelli, Diana, Testori, Alessandro, Ridolfi, Ruggero, Maio, Michele
Publicado em 2013

Sun exposure and melanoma prognostic factors

Por GANDINI, SARA, MONTELLA, MAURIZIO, AYALA, FABRIZIO, BENEDETTO, LUCIA, ROSSI, CARLO RICCARDO, VECCHIATO, ANTONELLA, CORRADIN, MARIA TERESA, DE GIORGI, VINCENZO, QUEIROLO, PAOLA, ZANNETTI, GUIDO, GIUDICE, GIUSEPPE, BORRONI, GIOVANNI, FORCIGNANÒ, ROSACHIARA, PERIS, KETTY, TOSTI, GIULIO, TESTORI, ALESSANDRO, TREVISAN, GIUSTO, SPAGNOLO, FRANCESCO, ASCIERTO, PAOLO A.
Publicado no Oncol Lett (2016)

Clinical experience with ipilimumab 3 mg/kg: real-world efficacy and safety data from an expanded access programme cohort

Por Ascierto, Paolo A, Simeone, Ester, Sileni, Vanna Chiarion, Pigozzo, Jacopo, Maio, Michele, Altomonte, Maresa, Del Vecchio, Michele, Di Guardo, Lorenza, Marchetti, Paolo, Ridolfi, Ruggero, Cognetti, Francesco, Testori, Alessandro, Bernengo, Maria Grazia, Guida, Michele, Marconcini, Riccardo, Mandalà, Mario, Cimminiello, Carolina, Rinaldi, Gaetana, Aglietta, Massimo, Queirolo, Paola
Publicado em 2014

Efficacy and safety of ipilimumab in elderly patients with pretreated advanced melanoma treated at Italian centres through the expanded access programme

Por Chiarion Sileni, Vanna, Pigozzo, Jacopo, Ascierto, Paolo Antonio, Grimaldi, Antonio Maria, Maio, Michele, Di Guardo, Lorenza, Marchetti, Paolo, de Rosa, Francesco, Nuzzo, Carmen, Testori, Alessandro, Cocorocchio, Emilia, Bernengo, Maria Grazia, Guida, Michele, Marconcini, Riccardo, Merelli, Barbara, Parmiani, Giorgio, Rinaldi, Gaetana, Aglietta, Massimo, Grosso, Marco, Queirolo, Paola
Publicado em 2014

Pediatric Melanoma: Analysis of an International Registry

Por Averbook, Bruce J., Lee, Sandra J., Delman, Keith A., Gow, Kenneth W., Zager, Jonathan S., Sondak, Vernon K., Messina, Jane L., Sabel, Michael S., Pittelkow, Mark R., Ecker, Phillip M., Markovic, Svetomir N., Swetter, Susan M., Leachman, Sancy A., Testori, Alessandro, Curiel-Lewandrowski, Clara, Go, Ronald S., Jukic, Drazen M., Kirkwood, John M.
Publicado em 2013

Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

Por Chapman, Paul B., Hauschild, Axel, Robert, Caroline, Haanen, John B., Ascierto, Paolo, Larkin, James, Dummer, Reinhard, Garbe, Claus, Testori, Alessandro, Maio, Michele, Hogg, David, Lorigan, Paul, Lebbe, Celeste, Jouary, Thomas, Schadendorf, Dirk, Ribas, Antoni, O’Day, Steven J., Sosman, Jeffrey A., Kirkwood, John M., Eggermont, Alexander M.M., Dreno, Brigitte, Nolop, Keith, Li, Jiang, Nelson, Betty, Hou, Jeannie, Lee, Richard J., Flaherty, Keith T., McArthur, Grant A.
Publicado em 2011

Safety and efficacy of vemurafenib in BRAF(V600E) and BRAF(V600K) mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study

Por McArthur, Grant A, Chapman, Paul B, Robert, Caroline, Larkin, James, Haanen, John B, Dummer, Reinhard, Ribas, Antoni, Hogg, David, Hamid, Omid, Ascierto, Paolo A, Garbe, Claus, Testori, Alessandro, Maio, Michele, Lorigan, Paul, Lebbé, Celeste, Jouary, Thomas, Schadendorf, Dirk, O’Day, Stephen J, Kirkwood, John M., Eggermont, Alexander M, Dréno, Brigitte, Sosman, Jeffrey A, Flaherty, Keith T, Yin, Ming, Caro, Ivor, Cheng, Suzanne, Trunzer, Kerstin, Hauschild, Axel
Publicado no Lancet Oncol (2014)